FDA inspection
Wuxi Biologics Co Ltd: FDA inspection ending Apr 16, 2019
FDA inspection 1086695 · Voluntary Action Indicated (VAI) · Wuxi
Key facts
| Inspection ID | 1086695 |
|---|---|
| Firm | Wuxi Biologics Co Ltd |
| FEI number | 3010606982 |
| Address | 108 Meiliang Road, Binhu |
| City | Wuxi |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | Apr 16, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data